ADPT(Adaptive Biotechnologies Corporation) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $154.34M | $185.31M | $170.28M | $178.96M | $276.98M |
| 毛利润 | $105.04M | $127.40M | $94.72M | $106.88M | $205.62M |
| 营业利润 | −$208.97M | −$200.19M | −$227.03M | −$162.55M | −$57.12M |
| 净利润 | −$207.28M | −$200.19M | −$225.25M | −$159.49M | −$59.50M |
| 经营现金流 | −$192.73M | −$183.94M | −$156.32M | −$95.21M | −$45.99M |
| 自由现金流 | −$254.47M | −$200.29M | −$167.02M | −$98.88M | −$48.95M |
| 摊薄每股收益 | $-1.48 | $-1.40 | $-1.56 | $-1.08 | $-0.39 |